Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma

The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma Nucl Med Mol Imaging (2017) 51:69–78 DOI 10.1007/s13139-016-0440-y ISSN (print) 1869-3482 ORIGINAL ARTICLE ISSN (online) 1869-3474 The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma 1 1 1 1 1 Yeongjoo Lee & Ie Ryung Yoo & Sun Ha Boo & Hyoungwoo Kim & Hye Lim Park & Joo Hyun O Received: 18 April 2016 /Revised: 20 June 2016 /Accepted: 14 July 2016 /Published online: 6 August 2016 Korean Society of Nuclear Medicine 2016 Abstract MTV, and TLG for the primary tumor were 8.2 ± 3.1, 6.8 ± 2.5, Purpose The aim of this study was to evaluate the diagnostic 4.0 ± 0.8, 192.7 ± 360.5 cm , and 823.7 ± 1615.4, respectively. and prognostic role of metabolic parameters of FDG PET/CT Patients with higher (≥7.3, HR: 4.280, p = 0.001), higher in patients with intrahepatic cholangiocarcinoma (ICC). SUVpeak (≥6.5, HR: 2.333, p = 0.020), higher SUVmean Methods From December 2008 to December 2013, 76 FDG (≥3.9, HR: 2.799, p = 0.004), higher SUVgluc (≥8.1, HR: PET/CT scans performed for initial staging of ICC in a single 2.648, p = 0.012), and higher TLGgluc (≥431.6, HR: 2.186, institution (57 male and 19 female; mean age 68 ± 9 years) http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nuclear Medicine and Molecular Imaging Springer Journals

The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma

Loading next page...
 
/lp/springer-journals/the-role-of-f-18-fdg-pet-ct-in-intrahepatic-cholangiocarcinoma-CtcmMtxT42

References (33)

Publisher
Springer Journals
Copyright
Copyright © 2016 by Korean Society of Nuclear Medicine
Subject
Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
ISSN
1869-3474
eISSN
1869-3482
DOI
10.1007/s13139-016-0440-y
Publisher site
See Article on Publisher Site

Abstract

Nucl Med Mol Imaging (2017) 51:69–78 DOI 10.1007/s13139-016-0440-y ISSN (print) 1869-3482 ORIGINAL ARTICLE ISSN (online) 1869-3474 The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma 1 1 1 1 1 Yeongjoo Lee & Ie Ryung Yoo & Sun Ha Boo & Hyoungwoo Kim & Hye Lim Park & Joo Hyun O Received: 18 April 2016 /Revised: 20 June 2016 /Accepted: 14 July 2016 /Published online: 6 August 2016 Korean Society of Nuclear Medicine 2016 Abstract MTV, and TLG for the primary tumor were 8.2 ± 3.1, 6.8 ± 2.5, Purpose The aim of this study was to evaluate the diagnostic 4.0 ± 0.8, 192.7 ± 360.5 cm , and 823.7 ± 1615.4, respectively. and prognostic role of metabolic parameters of FDG PET/CT Patients with higher (≥7.3, HR: 4.280, p = 0.001), higher in patients with intrahepatic cholangiocarcinoma (ICC). SUVpeak (≥6.5, HR: 2.333, p = 0.020), higher SUVmean Methods From December 2008 to December 2013, 76 FDG (≥3.9, HR: 2.799, p = 0.004), higher SUVgluc (≥8.1, HR: PET/CT scans performed for initial staging of ICC in a single 2.648, p = 0.012), and higher TLGgluc (≥431.6, HR: 2.186, institution (57 male and 19 female; mean age 68 ± 9 years)

Journal

Nuclear Medicine and Molecular ImagingSpringer Journals

Published: Aug 6, 2016

There are no references for this article.